ASSETMARK, INC

Position in LKFT — Lakefront Biotherapeutics NV

CIK 1344551 CONCORD, CA

Position in LKFT

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$7,674

+$6,924 QoQ

Shares Held

256

+924.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#58

of 78 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ASSETMARK, INC holds $347,870,398 across 92 Biotechnology names. LKFT ranks #61 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	3,433,824	$186,834,363
2	VRTX	Vertex Pharmaceuticals Inc / Ma	61,055	$30,327,850
3	DFTX	Definium Therapeutics, Inc.	396,542	$18,653,335
4	HALO	Halozyme Therapeutics, Inc.	174,334	$13,645,122
5	PTGX	Protagonist Therapeutics, Inc	98,687	$12,097,052
6	ONC	BeOne Medicines Ltd.	32,399	$9,232,743
7	REGN	Regeneron Pharmaceuticals, Inc.	12,594	$7,852,862
8	ARGX	Argenx SE	7,699	$7,142,901

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,674	256	+924.0%	Shares	Sole	2026-07-30
2026-03-31	$750	25	+13.6%	Shares	Sole	2026-05-06
2025-12-31	$719	22	-47.6%	Shares	Sole	2026-01-23
2025-09-30	$1,454	42	+250.0%	Shares	Sole	2025-11-06
2025-06-30	$335	12	-93.0%	Shares	Sole	2025-08-04
2021-09-30	$8,996	171	0.0%	Shares	Sole	2021-11-12
2021-06-30	$11,780	171	-78.9%	Shares	Sole	2021-08-16
2021-03-31	$62,597	812	-75.8%	Shares	Sole	2021-05-14
2020-12-31	$331,681	3,351	-50.7%	Shares	Sole	2021-02-10
2020-09-30	$964,704	6,798	+15.3%	Shares	Sole	2020-11-13
2020-06-30	$1,163,221	5,896	+8.3%	Shares	Sole	2020-08-11
2020-03-31	$1,066,392	5,443	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.